Prevest Denpro Ltd. · BSE:PREVEST

Prevest Denpro — FY2026 Earnings Presentation

29 slides from Prevest Denpro's earnings presentation, Jun 27, 2026

  1. Slide 1: BSE submission letter for Investor Presentation

    June 27, 2026 To BSE Limited, Corporate Relationship Department, P.J. Towers, Dalal Street, Mumbai 400 001 Scrip No. 543363 Subject: Submission of Investor Presentation to be made to Analysts/Investors. Dear Sir/Madam, Please find enclosed herewith the Investor Presentation to be made to Analysts/In

  2. Slide 2: Investor Presentation FY 2025-2026: FY26 Financial Results

    PREVESTDenPro° THE FUTURE OF DENTISTRY INVESTOR PRESENTATION FY 2025-2026 FY26 Financial Results Prevest Denpro Limited | Redefining Dental Excellence Financial Year Ended March 31, 2026

  3. Slide 3: Disclaimer

    Investor’s Disclaimer Presentation This presentation and the accompanying slides ( the “Presentation” ), which have been prepared by Prevest Denpro Ltd. (the “Company” ), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or s

  4. Slide 4: Chairman's Message

    Investor’s Chairman’s Message Presentation FY 25-26 has been a year of remarkable growth and resilience for Prevest Denpro Limited. Despite a dynamic macroeconomic environment, our steadfast focus on operational excellence and product quality has driven sustained success. I am pleased to report that

  5. Slide 5: About Us

    Investor’s About Us Presentation Prevest Denpro Limited, established in 1999, is a leading Indian manufacturer of dental materials and consumables. Headquartered in Jammu, India, Prevest began with a modest 200-square-foot facility and has since expanded to a 60,000-square-foot, state-of-the-art man

  6. Slide 6: Product Portfolio

    Investor’s Product Portfolio Presentation Prevest Denpro offers a comprehensive range of dental products, designed to meet the varied needs of dental practices worldwide. Our product categories include: Restorative Materials: Durable, high-performance cavity restoration solutions (Crysta Restorative

  7. Slide 7: Mission Vision

    Investor’s Presentation Mission Vision To enhance global oral health with To be global leader in dental products Innovative, high quality dental known for quality, innovation and products. customer service.

  8. Slide 8: Awards & Recognitions

    Investor’s AWARDS & RECOGITIONS Presentation ASSOCHAM TRADE CONCLAVE 3D GEM 12TH Global SME Excellence Awards Vyapar Ratna Award 3D Gem Awards 2025

  9. Slide 9: Quality Accreditations

    Investor’s QUALITY ACCREDITATIONS Presentation With a focus on product quality, the company has successfully implemented a very effective quality management system which has been approved by TUV SUD, Germany. With the strong quality management system, all production processes are subjected to string

  10. Slide 10: Strategic Growth Timeline

    Investor’s STRATEGIC GROWTH TIMELINE Presentation 2021 2024 2025 2026 IPO USA MOU’S & UAE UAE Public listing on BSE SME, Axiodent Inc. established MOU with Indian Dental Capital infusion in establishing governance to capture the world's Association for clinical Prevest Gulf LLC, foundation. largest

  11. Slide 11: Business Highlights

    Investor’s Presentation Export to over +90 Countries Business worldwide Highlights +145 Dealers in India +120 Overseas Business Partners

  12. Slide 12: FY26 Business Highlights

    Investor’s FY26 Business Highlights Presentation Global Expansion R&D Excellence Operational Scale Strategic entry into US markets High-margin "Oradox" range rollout 60,000 sq. ft. facility optimized and UAE markets via Axiodent Inc. and 3D printing resin portfolio for peak manufacturing and footpri

  13. Slide 13: Top 10 Performing Products By Sale

    Investor’s Top 10 Performing Presentation Products By Sale Endoseal Oratemp C&B Orafil G MICRON SUPERIOR Fusion Ultra DC Fusion Flo Crysta Restorative Alvocure Fusion Flo 3 x 2g Fusion Bond 7

  14. Slide 14: Key Financial Performance

    Investor’s Key Financial Performance Presentation 7,166 39.8% EBITDA Margin Total Revenue from operations (INR Lakhs, on 2,142 standalone basis) PAT (INR Lakhs) +13.6% YoY Growth

  15. Slide 15: Revenue Growth Benchmarking

    Investment Investor’s Revenue Growth Benchmarking Presentation Presentation INR Lakhs Consolidated FY26 7,180.85 +13.9% Standalone FY26 7,166.42 +13.6% Consolidated FY25 6,302.81 Base Standalone FY25 6,306.77 Base Consistently achieving high double-digit growth across both operations.

  16. Slide 16: Investor's Presentation (On Standalone Basis)

    Investor’s Presentation (On Standalone Basis)

  17. Slide 17: Investor's Presentation (On Consolidated Basis)

    Investor’s Presentation (On Consolidated Basis)

  18. Slide 18: Consolidated Financials

    Investment Investor’s Consolidated Financials Presentation Presentation % CHANGE (YOY) % CHANGE PARTICULAR (INR Lakhs) H2 FY 25-26 H1 FY 25-26 H2 FY 24-25 (H2 FY26 VS H1 FY26) Revenue from Operations 3,740.01 3,440.84 3,340.16 +11.97% +8.69% Total Income 3,995.71 3,676.65 3,556.58 +12.35% +8.68% EBI

  19. Slide 19: Standalone Financials

    Investment Investor’s Standalone Financials Presentation Presentation % CHANGE (YOY) % CHANGE PARTICULAR (INR Lakhs) H2 FY 25-26 H1 FY 25-26 H2 FY 24-25 (H2 FY26 VS H1 FY26) Revenue from Operations 3,727.85 3,438.57 3,346.87 +11.38% +8.41% Total Income 3,990.11 3,676.02 3,564.87 +11.93% +8.54% EBITD

  20. Slide 20: Investor's Presentation

    Investment Investor’s Presentation Presentation

  21. Slide 21: Investor's Presentation (On Standalone Basis)

    Investor’s Presentation (On Standalone Basis)

  22. Slide 22: New Product Lines: Digital Dentistry and Hygiene & Disinfectants

    Investor’s New Product Lines Presentation DIGITAL HYGIENE & DENTISTRY DISINFECTANTS

  23. Slide 23: Growth Strategies

    Investor’s Growth Strategies Presentation Diversification Market Penetration Market Development Product Development Ecommerce Expansion Expanding into advanced Increasing market share Expanding globally by Investing in R&D to develop Strengthening the Prevest dental consumables, digital through bran

  24. Slide 24: Domestic Market Advancement

    Investor’s Presentation Tier II & III Expansion: Aggressively penetrate underserved, high-growth markets. Distribution Scale-Up: Strengthen dealer & distributor network for wider reach and faster delivery. Demand Generation: Activate targeted campaigns and deepen engagement with dentists & instituti

  25. Slide 25: Strategic Diversification

    Investor’s Presentation Expand beyond traditional dental materials into digital dentistry, 3D printing, resins, disinfectants and preventive oral care. Broaden offerings across restorative, prosthodontic, endodontic, and orthodontic segments. Strengthen market penetration through wider distribution

  26. Slide 26: Key Dental Market Trends

    Investor’s Presentation The global dental market is witnessing strong growth, projected to reach ~USD 41 billion in 2025 with a CAGR of about 11.5% through 2032. Demand is driven by rising awareness of oral health, ageing populations, and increasing preference for aesthetic and cosmetic dental proce

  27. Slide 27: Prevest Research Centre

    Investor’s Presentation Prevest Research Centre Innovation & Development: Creates advanced dental materials and technologies. Quality Enhancement: Ensures high safety, efficacy, and durability. Customization: Delivers tailored solutions for specific client needs. Faster Time-to-Market: Accelerates p

  28. Slide 28: The Future: FY27

    Investor’s The Future: FY27 Presentation New Categories: Expanding into Digital Dentistry and Disinfectants to drive future growth. Domestic Expansion: Strengthening presence in Tier I & Tier II markets with new product category launches. Global Growth: Entering new international markets and increas

  29. Slide 29: Questions?

    Investor’s Presentation Questions? Thank you for your continued trust in Prevest Denpro. cs@prevestdenpro.com www.prevstdenpro.com

Prevest Denpro — FY2026 Earnings Presentation on 6ix